Also, in a mouse model of CAC established by AOM/DSS treatment, celastrol (2 mg/kg/d for 14 weeks) was observed to significantly decrease the levels of oncogenic proteins such as p53 and β-catenin. Here, TP53 is linked to infectious otitis media.